Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-01-01Clinical Trial Update: Gastric Bypass After Previous Anti-reflux Surgery
A completed clinical trial update from UCSF on gastric bypass after prior anti-reflux surgery, involving individuals with obesity and gastro…
-
CLINICAL_TRIALS trial_result · 2009-12-29Clinical Trial Update: Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ
This completed AstraZeneca-sponsored clinical trial update examines the prevalence of gastroesophageal reflux disease and its impact on work…
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD) [Phase 2]
A Phase 2 study evaluating ADX10059 as monotherapy for gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)
This clinical trial update reports completion of a study evaluating a management strategy for gastroesophageal reflux disease (GERD) sponsor…
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Comparison of Laparoscopic Nissen Versus Thal Fundoplication in Children [NA]
A pediatric trial comparing laparoscopic Nissen fundoplication with Thal fundoplication for gastroesophageal reflux disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole [Phase 2]
Phase 2 clinical trial results evaluating rabeprazole for gastroesophageal reflux disease in adolescents aged 12-16 were posted.
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: Maintenance Intermittent Therapy for Symptomatic GERD Patients [Phase 2]
Phase 2 clinical trial update evaluating maintenance intermittent therapy for symptomatic Gastroesophageal Reflux Disease. The study results…
-
FDA approval · 2009-12-01FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved Ipca Laboratories Limited's supplemental application for Metoclopramide, granting approval of a generic version of the drug. Th…
-
FDA approval · 2009-11-18FDA Approved: NIZATIDINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's nizatidine original application (generic) for use in conditions treated by H2 blockers.
-
CLINICAL_TRIALS trial_result · 2009-11-17Clinical Trial Update: Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD) [Phase 3]
Phase 3 safety and efficacy study of Axid (nizatidine) in infants with gastroesophageal reflux disease has completed with results posted.
-
CLINICAL_TRIALS research · 2009-11-17Clinical Trial Update: National Survey on GERD Patients (Adults and Children)
AstraZeneca-sponsored national survey of adults and children with gastroesophageal reflux disease has completed.
-
FDA approval · 2009-11-10FDA Approved: LANSOPRAZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved an original ANDA for lansoprazole from Teva Pharmaceuticals USA, Inc., allowing a generic version of the proton pump inhibitor.…
-
FDA approval · 2009-11-10FDA Approved: LANSOPRAZOLE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved Mylan Pharmaceuticals Inc.'s Original Application for a generic lansoprazole (Lansoprazole) under ANDA090763. Lansoprazole …
-
FDA approval · 2009-11-06FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's metoclopramide product, updating its regulatory status as a marketed generic drug.
-
CLINICAL_TRIALS trial_result · 2009-09-22Clinical Trial Update: Necessity of Esophageal Dissection During Laparoscopic Fundoplication [NA]
This completed clinical trial evaluated whether esophageal dissection is necessary during laparoscopic fundoplication for gastroesophageal r…
-
FDA approval · 2009-09-21FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole). This action typically updates labeling, manu…
-
FDA approval · 2009-09-16FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for METOCLOPRAMIDE, authorizing the manufacture and marketing of a generic me…
-
FDA approval · 2009-09-11FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for METOCLOPRAMIDE HYDROCHLORIDE submitted by Chartwell Governmental & Specialty RX, LLC.
-
CLINICAL_TRIALS trial_result · 2009-09-10Clinical Trial Update: Evaluation of Patients With Non-cardiac Chest Pain [Phase 4]
Phase 4 clinical trial update examining evaluation of patients with non-cardiac chest pain and gastroesophageal reflux disease; the study st…
-
FDA approval · 2009-09-04FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for REGLAN (metoclopramide hydrochloride), enabling changes under a supplemen…
-
FDA approval · 2009-08-31FDA Approved: RANITIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ranitidine by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial comparing dexlansoprazole MR to placebo to maintain healing in subjects with healed erosive esophagitis; results posted in 200…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dexlansoprazole MR vs placebo in maintaining healing in patients with healed erosive eso…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating dexlansoprazole MR for maintaining healing in subjects with previously healed erosive esophagitis; results and safe…
-
CLINICAL_TRIALS trial_result · 2009-08-12Clinical Trial Update: Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Phase 3]
Phase 3 safety and quality-of-life results for a dexlansoprazole modified-release formulation in gastroesophageal reflux disease have been p…